Johnson & Johnson Covid 19 Vaccine - Epidemiology

Relevant Publications

Issue Release: 2024

Association of COVID-19 Vaccinations with Flares of Systemic Rheumatic Disease: A Case-Crossover Study.

Issue Release: 2024

Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Bamako, Mali: A Population-Based Cross-Sectional Study in September 2022.

Issue Release: 2024

The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review.

Issue Release: 2024

Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa.

Issue Release: 2024

Response of Unvaccinated US Adults to Official Information About the Pause in Use of the Johnson & Johnson-Janssen COVID-19 Vaccine: Cross-Sectional Survey Study.

Issue Release: 2024

Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response.

Issue Release: 2024

Anti-PF4 positivity and platelet activation after Ad26.COV2·S vaccination in Brazil.

Issue Release: 2024

Short term Outcomes of COVID-19 Vaccines Among Lactating Mother and Child Dyads in Bangladesh: A Multi-centre, Cross-sectional Study.

Issue Release: 2024

Factors affecting COVID-19 vaccine uptake in populations with higher education: insights from a cross-sectional study among university students in Malawi.

Issue Release: 2024

COVID-19 vaccination in healthcare workers: Long-term benefits and protection.

Issue Release: 2024

Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response.

Issue Release: 2024

Post-COVID-19 Vaccine Thromboembolic Complication in the Setting of Newly Diagnosed May-Thurner Syndrome.

Issue Release: 2024

A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID-19 vaccination: The good, the bad, and the ugly.

Issue Release: 2024

Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco.

Issue Release: 2024

Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review.

Issue Release: 2024

Establishment of human post-vaccination SARS-CoV-2 standard reference sera.

Issue Release: 2024

Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged ≥ 12 years, United States, August 2021-October 2022.

Issue Release: 2024

Cranioplasty after Decompressive Craniectomy (DC) in a Patient with Intracerebral Hemorrhage after SARS-CoV-2 Vaccination-Related Vaccine-Induced Thrombotic Thrombocytopenia (VITT)-Proposal of a Management Protocol for This Rare Pathological Condition.

Issue Release: 2024

Humoral immune response as an indicator for protection against Covid-19 after anti-SARS-COV2-booster vaccination in hematological and oncological patients.

Issue Release: 2024

What are the Applications of Micro Costing in Epidemiology?

What is Public Health Data?

How Does WWF Help in Disease Prevention?

What Are the Public Health Responses to Novel Pathogens?

What are the Challenges in Implementing Enhanced Cleaning Protocols?

What Causes Distrust in Authorities?

Why are Immunosuppressants Important?

What Methods are Used to Study Microbial Metabolites?

Why is Biological Variability Important in Epidemiology?

How Does Emigration Influence Healthcare Systems?

Johnson & Johnson Covid 19 Vaccine - Epidemiology

Relevant Publications

Partnered Content Networks

Relevant Topics